European Distribution. Structured Partnership.

We work exclusively through qualified distribution partners. Our programme is designed to reduce operational friction, provide regulatory certainty, and build long-term commercial value across the European IVD market.

Why Distribute CCI Reagent?

The European in-vitro diagnostics market is evolving. Preventive screening is gaining traction across pharmacy, hospital, and laboratory channels. Orientational tyrosine testing represents an emerging category with genuine clinical relevance and growing institutional demand.

CCI Reagent is not a commodity product competing on price alone. It is a CE-IVD certified medical device with full regulatory documentation, a defined supply chain, and a commercial model built around partner success. We provide the infrastructure — you provide the market access.

Built Around Your Operations

Regulatory Clarity

Complete CE-IVD technical documentation, Instructions for Use in local languages, and a defined IVDR transition pathway. Post-market surveillance is managed centrally, with distributor reporting templates provided.

Commercial Model

Tiered pricing based on volume commitment. Transparent margin structures, defined payment terms, and territory exclusivity options. No hidden fees or retrospective clawbacks.

Logistics & Supply

Room-temperature storage. 24-month shelf life. Defined MOQ, pallet configurations, and lead times. Consistent supply with no seasonal disruption or allocation risk.

Market Support

Localised marketing assets, sales training kits, clinical data summaries, and product explainers. Dedicated partner manager for the first 90 days. Ongoing co-marketing support for tender submissions.

Take the Next Step

Whether you are exploring the opportunity or ready to formalise a partnership, we are here to support your evaluation.

Become a Distributor Request Distributor Pack